[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81856]], camposKey:1367-0484 2024-02-01 Clinical characterisation of contact lens discomfort progression00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81857]], camposKey:1542-0124 2024-01-01 Gene expression changes in conjunctival cells associated with contact lens wear and discomfort3142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81159]], camposKey:0275-5408 2024-01-01 Reliability and agreement of subjective and objective non-invasive break-up time measurements in contact lens wearers124130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72870]], camposKey:2045-2322 2022-10-06 Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75140]], camposKey:1542-0124 2022-10-01 Phenotypic characterization of patients developing chronic dry eye and pain after refractive surgery: A cross-sectional study6374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75093]], camposKey:0146-0404 2022-06-01 Evaluation of gene expression in conjunctival epithelial cells associated with contact lens wear and discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72871]], camposKey:0014-4835 2022-06-01 Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75092]], camposKey:0146-0404 2022-06-01 Ophthalmic 0.1% Cyclosporine A Cationic Emulsion Improves Keratitis After the First Month of Therapy in Dry Eye Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75174]], camposKey:0146-0404 2022-06-01 Topical Ophthalmic Delivery of Quercetin and Resveratrol using Elastin-like Recombinamer Nanoparticles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75766]], camposKey:2304-8158 2022-02-01 Potential Ophthalmological Application of Extracts Obtained from Tuna Vitreous Humor Using Lactic Acid-Based Deep Eutectic Systems00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65275]], camposKey:1367-0484 2022-02-01 The R-evolution of contact lenses: Will long-term contact lens wearers in the future be the same as now?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75091]], camposKey:1367-0484 2022-01-01 Diurnal variation on tear stability and correlation with tear cytokine concentration1017050, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75173]], camposKey:0378-5173 2022-01-01 Improved ocular delivery of quercetin and resveratrol: A comparative study between binary and ternary cyclodextrin complexes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72872]], camposKey:1367-0484 2022-01-01 Is contact lens discomfort related to meibomian gland morphology?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75765]], camposKey:2077-0383 2022-01-01 Olive Pomace Phenolic Compounds: From an Agro-Industrial By-Product to a Promising Ocular Surface Protection for Dry Eye Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65276]], camposKey:1367-0484 2021-12-01 Usefulness of a global rating change scale for contact lens discomfort evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65277]], camposKey:1367-0484 2021-08-01 Does placebo effect exist in contact lens discomfort management?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66297]], camposKey:1542-2321 2021-05-01 Contact Lens Discomfort Management: Outcomes of Common Interventions256264, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81898]], camposKey:1420-3049 2021-01-02 Ocular delivery of polyphenols: Meeting the unmet needs00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59745]], camposKey:1692-8415 2021-01-01 Cambios en la calidad visual asociados al uso de las lentes de contacto Biofinity Energys00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65278]], camposKey:0816-4622 2021-01-01 Design of a questionnaire for detecting contact lens discomfort: the Contact Lens Discomfort Index00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66298]], camposKey:1542-2321 2021-01-01 Development of a Questionnaire for Detecting Changes in Dry Eye Disease-Related Symptoms814, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59335]], camposKey:1542-0124 2020-10-01 Inflammatory status predicts contact lens discomfort under adverse environmental conditions829840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66299]], camposKey:0146-0404 2020-06-01 CHARACTERIZATION OF PATIENTS DEVELOPING CHRONIC DRY EYE AND PAIN AFTER REFRACTIVE SURGERY00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73183]], camposKey:1692-8415 2020-01-01 Caracterización de los síntomas derivados del uso de pantallas por dispositivos electrónicos en una población universitaria00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52801]], camposKey:0014-4835 2020-01-01 Clinical and tear cytokine profiles after advanced surface ablation refractive surgery: A six-month follow-up00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52911]], camposKey:1542-2321 2020-01-01 Development of a Questionnaire for Detecting Changes in Dry Eye Disease-Related Symptoms00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59743]], camposKey:2173-9366 2020-01-01 Efecto de las lentes de contacto con diseño Digital Zone OpticsTM en la sintomatología, visión y variables clínicas en usuarios de lentes de contacto5458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52802]], camposKey:0929-8673 2020-01-01 Tear inflammatory molecules in contact lens wearers: A literature review523548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53217]], camposKey:1367-0484 2019-01-01 Analysis of the placebo effect in comfort during contact lens wear00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42956]], camposKey:0275-5408 2019-01-01 Changes in the tarsal conjunctiva viewed by in vivo confocal microscopy are associated with ocular symptoms and contact lens wear328336, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53436]], camposKey:1367-0484 2019-01-01 Characterization of Computer Vision Syndrome in a university population00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52942]], camposKey:0927-3948 2019-01-01 Conjunctival Neuropathic and Inflammatory Pain-Related Gene Expression with Contact Lens Wear and Discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53435]], camposKey:1367-0484 2019-01-01 Design and development of a new questionnaire: contact lens discomfort index00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53433]], camposKey:1367-0484 2019-01-01 Effect of digital zone optics® design contact lenses in symptoms, vision and clinical variables00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53437]], camposKey:1367-0484 2019-01-01 Inflammatory mediators and substance p in tears during contact lens discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53363]], camposKey:1367-0484 2019-01-01 Is contact lens discomfort related to the morphology and function of the Meibomian glands?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53434]], camposKey:1367-0484 2019-01-01 Is there any difference in the ocular surface between subjects with and without contact lens discomfort?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41511]], camposKey:1542-0124 2019-01-01 Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes502515, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52943]], camposKey:0927-3948 2019-01-01 Substance P Level in Tears as a Potential Biomarker for Contact Lens Discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41510]], camposKey:1367-0484 2019-01-01 The ability of the Contact Lens Dry Eye Questionnaire (CLDEQ)-8 to detect ocular surface alterations in contact lens wearers273277, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42955]], camposKey:0927-3948 2019-01-01 Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease10231032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11553]], camposKey:0271-3683 2018-01-01 Are Contact Lens Discomfort or Soft Contact Lens Material Properties Associated with Alterations in the Corneal Sub-Basal Nerve Plexus?487492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53812]], camposKey:1367-0484 2018-01-01 Effect of the environmental conditions on tear inflammatory mediators concentration in contact lens wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42494]], camposKey:1542-2321 2018-01-01 Reliability of Blotting Techniques to Assess Contact Lens Water Content227232, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37802]], camposKey:1542-0124 2018-01-01 Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial368376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3536]], camposKey:1542-0124 2018-01-01 Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears8492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53813]], camposKey:1755-375X 2017-01-01 Corneal confocal microscopy assessment in contact lens discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3534]], camposKey:0020-8167 2017-01-01 Effects of the external environment on dry eye disease2340, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8941]], camposKey:1542-2321 2017-01-01 Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease5763, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3535]], camposKey:0275-5408 2017-01-01 Ocular response to environmental variations in contact lens wearers6070, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3533]], camposKey:0161-6420 2017-01-01 Reply02, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37803]], camposKey:1542-2321 2017-01-01 Safety and Efficacy of an Artificial Tear Containing 0.3% Hyaluronic Acid in the Management of Moderate-to-Severe Dry Eye Disease383388, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3543]], camposKey:0146-0404 2016-01-01 Biomarkers in ocular chronic graft versus host disease: Tear cytokine- and chemokine-based predictive model746758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3541]], camposKey:0002-9394 2016-01-01 Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients under Desiccating Stress00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3537]], camposKey:1040-5488 2016-01-01 Corneal sensitivity and inflammatory biomarkers in contact lens discomfort892900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3538]], camposKey:0277-3740 2016-01-01 Effect of environmental conditions on the concentration of tear inflammatory mediators during contact lens wear11921198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8943]], camposKey:1367-0484 2016-01-01 Effect of the osmolarity change in multipurpose solutions induced by an improper contact lens case cleaning procedure177184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3539]], camposKey:1040-5488 2016-01-01 Lack of agreement among electrical impedance and freezing-point osmometers482487, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39503]], camposKey:0146-0404 2016-01-01 Tear fluid proteome reveals inflammation and immune response proteins as potential predictive biomarkers of the effects of desiccating stress and dry eye treatments00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3542]], camposKey:0161-6420 2016-01-01 Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial141153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56663]], camposKey:0146-0404 2015-06-01 Gene expression-based predictive models of Graft versus Host Disease-associated Dry Eye00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53811]], camposKey:1367-0484 2015-01-01 Analysis of visual function and tear film stability in contact lens wearers with one-day disposable contact lenses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10829]], camposKey:1367-0484 2015-01-01 End-of-day dryness, corneal sensitivity and blink rate in contact lens wearers148151, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8939]], camposKey:1755-375X 2015-01-01 Environmental factors in ocular surface disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29864]], camposKey:1888-4296 2015-01-01 Evaluation of safety and efficacy of a new multipurpose disinfecting solution on silicone hydrogel contact lenses4047, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3547]], camposKey:0146-0404 2015-01-01 Gene expression-based predictive models of graft versus host disease-associated dry eye45704581, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8944]], camposKey:0271-3683 2015-01-01 In Vitro Model for Predicting the Protective Effect of Ultraviolet-Blocking Contact Lens in Human Corneal Epithelial Cells792799, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3545]], camposKey:1040-5488 2015-01-01 Influence of climate on clinical diagnostic dry eye tests: Pilot study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3544]], camposKey:0146-0404 2015-01-01 Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells27092719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=768]], camposKey:0271-3683 2014-01-01 Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance673679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=788]], camposKey:0002-9394 2014-01-01 Dry Eye Exacerbation in Patients Exposed to Desiccating Stress under Controlled Environmental Conditions788798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=759]], camposKey:1552-4973 2014-01-01 Influence of environmental factors in the in vitro dehydration of hydrogel and silicone hydrogel contact lenses764771, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=751]], camposKey:0014-4835 2014-01-01 Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects4349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=792]], camposKey:0146-0404 2013-01-01 Influence of a Controlled Environment Simulating an In-Flight Airplane Cabin on Dry Eye Disease20932099, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8940]], camposKey:0886-3350 2013-01-01 Precision of higher-order aberration measurements with a new Placido-disk topographer and Hartmann-Shack wavefront sensor242249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=730]], camposKey:0146-0404 2012-01-01 Characterization by Belmonte's Gas Esthesiometer of Mechanical, Chemical, and Thermal Corneal Sensitivity Thresholds in a Normal Population31543160, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=736]], camposKey:0271-3683 2012-01-01 Correlations Among Symptoms, Signs, and Clinical Tests in Evaporative-Type Dry Eye Disease Caused by Meibomian Gland Dysfunction (MGD)855863, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=766]], camposKey:1040-5488 2011-01-01 Contact Lens Case Cleaning Procedures Affect Storage Solution pH and Osmolality14141421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3551]], camposKey:0365-6691 2011-01-01 Lack of concordance between dry eye syndrome questionnaires and diagnostic tests Falta de concordancia entre los cuestionarios y las pruebas diagnósticas en el síndrome de ojo seco37, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29497]], camposKey:0212-4394 2011-01-01 Procedimientos de valoración de la función visual en el síndrome de ojo seco3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29496]], camposKey:2173-9366 2011-01-01 Técnicas diagnósticas para el síndrome de ojo seco (I)1220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=790]], camposKey:0927-3948 2010-01-01 Dry Eye Disease as an Inflammatory Disorder244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=784]], camposKey:1040-5488 2009-01-01 Conjunctival Mucin mRNA Expression in Contact Lens Wear10511058, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29859]], camposKey:0212-4394 2008-01-01 Comparación de la tolerancia entre lentes de contacto de hidrogel de silicona y lentes de hidrogel convencional en uso diario539544, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=764]], camposKey:0146-0404 2007-01-01 Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye40264032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29868]], camposKey:0212-4394 2007-01-01 Líneas de investigación del Grupo de Superficie Ocular del IOBA218220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29869]], camposKey:0212-4394 2007-01-01 Sensibilidad corneal: una medida clave para la salud ocular618626, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=749]], camposKey:0146-0404 2004-01-01 Comparison of antioxidant enzymes genes expression changes in conjunctival epithelium induced by non ionic hydrogel contact lenses with different oxigen permeability.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=748]], camposKey:0146-0404 2004-01-01 Comparison of mucin genes expression alterations in conjunctival epithelium induced by high and low water content hydrogel contact lenses.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=782]], camposKey:0146-0404 2004-01-01 Corneal thickness changes after one year of hydrogel contact lens00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29865]], camposKey:0212-4394 2004-01-01 Frecuencia de síntomas oculares en usuarios de lentes de contacto hidrofílicas118121, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42584]], camposKey:1989-7111 2004-01-01 Soluciones contactológicas para el paciente con ojo seco marginal1926, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53793]], camposKey:0146-0404 2003-01-01 Antioxidant Enzyme Genes Expression in Conjunctival Epithelium of Normal Subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29858]], camposKey:0212-4394 2003-01-01 Baja visión en la población pediátrica325333, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29863]], camposKey:0212-4394 2003-01-01 Ergonomía visual y lectura3642, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29866]], camposKey:0212-4394 2003-01-01 Iluminación y ayudas ópticas en baja visión414419, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=781]], camposKey:0146-0404 2003-01-01 Levels of antioxidant enzyme genes in conjunctival impression cytology specimens from hydrogel contact lenses wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=770]], camposKey:0146-0404 2003-01-01 Low water content hydrogel contact lenses (HCL) induce corneal irregularity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=775]], camposKey:0146-0404 2003-01-01 Prospective variation in the expression of the conjunctival mucin genes Muc5ac, Muc7, Muc16, and Muc17 before, during and after contact lens wear00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=28754]], camposKey:0365-6691 2003-01-01 Síntomas y signos de ojo seco en usuarios de lentes de contacto hidrofílicas: relación con el hábito de fumar543547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29871]], camposKey:0212-4394 2003-01-01 Visión y conducción I: agudeza visual estática y campo visual1118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29872]], camposKey:0212-4394 2003-01-01 Visión y conducción II: factores visuales que intervienen en la seguridad en la conducción120126, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=756]], camposKey:0146-0404 2002-01-01 Comparison of ocular surface alterations induced by high and low water content hydrogel contact lenses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11679]], camposKey:0365-6691 2002-01-01 Functional improvement after vision rehabilitation in low monocular vision after myopic macular degeneration and retinal detachment Mejora funcional tras la rehabilitación visual en una paciente con visión monocular deficitaria debido a degeneración macular miópica y desprendimiento de retina.9598, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44578]], camposKey:0365-6691 2002-01-01 Mejora funcional tras la rehabilitación visual en una paciente con visión monocular deficitaria debido a degeneración macular miópica y desprendimiento de retina9597, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11680]], camposKey:0365-6691 2001-01-01 First results of the IOBA low vision unit Primeros resultados de la Unidad de Baja Visión del IOBA.719722][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13801]},camposKey: 141 148 Lentes de contacto para baja visión 8498358493Manual de Baja Visión y Rehabilitación Visual 1 null Editorial Médica Panamericana , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13796]},camposKey: 99 128 Alteración de la superficie ocular por el uso de lentes de contacto: problemas y soluciones actuales 978-84-937878-3-7Superficie ocular y biomateriales: lentes de contacto 1 2017-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13802]},camposKey: 125 138 Ojo seco 978-84-937878-3-7Superficie ocular y biomateriales: lentes de contacto 1 2017-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13804]},camposKey: 129 144 Síndrome de Ojo Seco 978-84-937878-3-7Superficie ocular y biomateriales: lentes de contacto 1 2017-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13799]},camposKey: 621 639 Efecto de las condiciones ambientales en la superficie ocular 8493965693Superficie Ocular y Lentes de Contacto 1 2013-01-01 Fundación Salud Visual, Desarrollo Optométrico y Audiólogico (FUNSAVI), CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19233]},camposKey: 102 119 Baja visión 8480868341Optometría. Aspectos avanzados y consideraciones especiales + StudentConsult en español 1 2011-12-16 Elsevier España , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=25998]},camposKey: 101 120 Baja visión 8480868341Optometría. Aspectos avanzados y consideraciones especiales + StudentConsult en español 1 2011-12-16 Elsevier España , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13797]},camposKey: Baja visión 978-84-8086-890-7Optometría. Aspectos Avanzados y Consideraciones Especiales 1 2011-01-01 Elsevier España, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13794]},camposKey: 563 576 Adaptaçao de LC em pacientes com olho seco marginal ou olho seco secundário à utilizaçao de LC 9729119783Contactologia 1 2005-01-01 José Manuel González-Méijome , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13798]},camposKey: 116 124 Características y epidemiología de la patología pediátrica optométrica 8493082821Optometría pediátrica 1 2005-01-01 Ulleye , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13803]},camposKey: 33 39 Proceso de adaptación de lentes de contacto hidrofílicas en uso prolongado 9788493082819Uso prolongado de lentes de contacto 1 2003-01-01 PublishAmerica, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=26005]},camposKey: 33 39 Proceso de adaptación de lentes de contacto hidrofílicas en uso prolongado. 8493082813Uso prolongado de lentes de contacto 1 2003-01-01 Ulleye , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3918]},camposKey: 23 0 Diseño de la ficha 8479087021Manual de prácticas de contactología 1 2002-01-01 Servicio de Publicaciones , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3917]},camposKey: 19 0 Historia del caso 8479087021Manual de prácticas de contactología 1 2002-01-01 Servicio de Publicaciones , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13800]},camposKey: 27 36 Importancia de las alteraciones visuales en los niños en edad escolar. Su detección 8479034890Problemas médicos en la escuela y su entorno 1 1999-01-01 -][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62305]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62473]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62074]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62113]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62159]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61941]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62315]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=60131]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62305]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62473]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62074]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62113]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62159]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61941]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62315]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=60131]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=77]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=76]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=74]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=78]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=73]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=75]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=77]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=76]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=74]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=78]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=73]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=75]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31266]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31116]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31035]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30651]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30320]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638267]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637347]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145641100]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636927]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636975]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636892]]][][][][][][com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=373]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=372]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=374]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=375]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=378]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=371]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=376]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=377]]][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6cc9ee9f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@37c6451e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7053c16c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@457a783a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6664cb1c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@630f9c7b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@db979d7, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1b146bf2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5b687fa7, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@441bdcf5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2aa7260, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3a59c23c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@22d40797, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@38329b4c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@695ac758, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1d66b06d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1f8cf4e9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3348f4af, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@c178599, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@245aa9ae, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5c893a70, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@289040c2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@189b3304, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@697dfe60, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7cb20385, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@568eca81, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@174cc047, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@11c4b230, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7d8635a6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5dfc3255, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2cc38f55, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@18a2edcf, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5445c078, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@68972e3f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@581ebd5f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@57ddef06, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2d61a385, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7c5686c0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@510f3850, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@691258a8, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@49cfa384, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1675cfb, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2902293f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@522ef3af, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6649a9ed, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5df2b15b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6501300b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4097048f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6b3acbb1, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@230ac7e4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4fe73ae6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@37acece9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@af6ceee, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7f361db3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@9f038b9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@596b56ca, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@655662b7, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2ac2202b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@227ff03a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@21a12fb9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@77b4b2e0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4ccc0745, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@11efc0c6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@391bf9a5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6bea6fd4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@47b0abc3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2836ba03, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4e06b871, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@762afaaa, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3406a91f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@297dfb3e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@52430b50, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@739d4418, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@72524525, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3430e45a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7ee36007, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@67475647, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7dc4ce7, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@34fd7a72, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@517bd7b2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@cd356b4][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5e6b38, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651d8e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651e02, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65230b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651344, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652433, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3e6951, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652319, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652465, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651c77, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6522bd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6512c2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6513c2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651d00, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651b7f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651ce0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651bc4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651bae, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651cdf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651afd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651b17, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6520d5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651679, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65209f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652162, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652107, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6520cd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651fb9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65213e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3739e2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6515e5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65213d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651507, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65157f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373427, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65212c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651ee1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37395c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650d07, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650d09, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650f0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373c83, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65169f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ca3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6516f4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ca2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65178f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372619, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37309a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65181a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651819, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651ef9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650df5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373afd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375241, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d74, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375244][][][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=59961]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60104]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60105]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60103]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60106]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=59961]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60104]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60105]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60103]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=60106]]][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1370]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1198]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1059]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1057]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1199]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3119], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3f62], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c4055], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5ba283], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3ffb], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@462669], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c4009], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41333e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412570], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3f95], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125d6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460600], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4120e4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411be8]][][][][][IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=106 ] ], IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=109 ] ], IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=105 ] ], IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=107 ] ], IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=108 ] ]][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1750c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1561d, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142ed, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14ad1, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14809, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13c5e, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14acb, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14ad2, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13c56, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14812, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14ad0, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1410e, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14acf, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14acd, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14acc, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14ace, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14ad3][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30591]},camposKey: 29 42 Biomarcadores de ojo seco en estudios clínicos 9788412227215Lentes de contacto y superficie ocular: biomateriales 1 2020-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30592]},camposKey: 43 54 Superficie ocular, lentes de contacto y condiciones ambientales 9788412227215Lentes de contacto y superficie ocular: biomateriales 1 2020-01-01 Ulleye]
